Gross tumor volume in sinonasal tract cancer as a predictor of local recurrence after chemoradiotherapy

Jpn J Clin Oncol. 2018 Dec 1;48(12):1041-1045. doi: 10.1093/jjco/hyy147.

Abstract

Objective: This study investigated whether gross tumor volume of the primary tumor before treatment was a predictor for local recurrence in patients with resectable sinonasal tract squamous cell carcinoma who were treated by chemoradiotherapy.

Methods: A total of 24 patients were enrolled. Pretreatment gross tumor volume of primary tumor was assessed by palpitation, perception and imaging. The cut-off value of the gross tumor volume for local recurrence was determined by receiver-operating curve analysis. A log-rank test and Cox's proportional hazards model were used for univariate and multivariate analyses with adjustment for the clinical T category (cT1-T4a/cT4b), respectively.

Results: In the univariate analysis, patients with the gross tumor volume ≥83.7 ml were significantly associated with shorter local recurrence-free rate (P = 0.0023) and disease-free survival (P = 0.0064) than those with gross tumor volume <83.7 ml. In the multivariate analysis, gross tumor volume ≥83.7 ml were significantly associated with shorter local recurrence-free rate (P = 0.041).

Conclusions: Pretreatment gross tumor volume of primary tumor ≥83.7 ml was significantly associated with local recurrence-free rate in resectable sinonasal tract squamous cell carcinoma.

MeSH terms

  • Carcinoma, Squamous Cell / complications*
  • Carcinoma, Squamous Cell / pathology
  • Carcinosarcoma / complications*
  • Carcinosarcoma / pathology
  • Chemoradiotherapy / adverse effects*
  • Chemoradiotherapy / methods
  • Female
  • Head and Neck Neoplasms / complications*
  • Head and Neck Neoplasms / pathology
  • Humans
  • Male
  • Middle Aged
  • Neoplasm Recurrence, Local / pathology*
  • Nose Neoplasms / complications*
  • Nose Neoplasms / pathology
  • Prognosis
  • Retrospective Studies
  • Teratoma / complications*
  • Teratoma / pathology
  • Tumor Burden / genetics*

Supplementary concepts

  • Malignant Teratocarcinosarcoma